nimotuzumab - CISMeF

Preferred Label : nimotuzumab;

MeSH note : a humanized monoclonal antibody for epidermal growth factor receptor for treatment of cancers of epithelial origin, such as breast, lung, head and neck, and pancreatic cancer;

CISMeF synonym : theraloc;

MeSH CAS label : immunoglobulin G1, anti-(humanized mouse monoclonal hR3 beta1 chain anti-human epidermal growth factor receptor), disulfide with humanized mouse monoclonal hR3 kappa-chain, dimer;

Is substance : O;

UNII : 6NS400BXKH;

Détails

Origin ID

C501466;

UMLS CUI

C1570308;

MeSH term(s) associated for indexing
- antibodies, monoclonal, humanized [MeSH Descriptor]
Pharmacological action(s)
- Antineoplastic Agents, Immunological [MeSH Descriptor]
Record concept(s)
- nimotuzumab [MeSH concept]
- theracim-HR3 [MeSH concept]
- theraloc [MeSH concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Nimotuzumab [NCIt concept]
- Nimotuzumab (substance) [SNOMED CT concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients